Cambridge, United States
Research view
Stroke: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
- All targets
- NLRP3 0
- NRF2 0
- GLP-1 4
- PCSK9 12
- AKT 0
- PI3K 0
- SGLT2 2
- BDNF 2
- TLR4 0
- AMPK 0
- STAT3 0
- mTOR 0
- VEGF 0
- ERK 0
- HIF-1 0
- PPAR 1
- SIRT1 0
- GPX4 0
- MMP-9 0
- STING 0
- HMGB1 0
- IL-6 0
- APOE 0
- JAK 0
- NOTCH3 1
- MAPK 0
- NMDA 0
- TNF 0
- TP53 0
- DPP-4 1
- CTNNB1 0
- CXCR4 0
- IL-1 1
- TREM2 0
- FTO 0
- IL-17 0
- JNK 0
- COX-2 0
- PTEN 0
- PARP 0
- YAP 0
- AQP4 0
- CCR5 1
- BCL-2 0
- EGFR 0
- PINK1 0
- HSP90 0
- AR 0
- GIP 0
- HDAC 0
- PD-L1 0
- PDE4 0
- PDGFR 0
- TFEB 0
- ATM 0
- B7-H3 0
- CGRP 0
- FOXP3 0
- MAPT 0
- MEK 0
EU-13 is a filter, not a ranking: it only narrows the list.
Beijing, China
Baltimore, United States
Boston, United States
Rochester, United States
New Haven, United States
Paris, France
Shanghai, China
Toronto, Canada
Los Angeles, United States
Boston, United States
Beijing, China
Hangzhou, China
Atlanta, United States
Shanghai, China
Stanford, United States
London, United Kingdom
San Francisco, United States
Philadelphia, United States
Calgary, Canada
Cleveland, United States
Beijing, China
Oxford, United Kingdom
New York, United States
24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
“Terminated based on results from the parent study, which did not meet its primary or secondary efficacy endpoints. The decision was not related to a safety.”Registry text, quoted unchanged. Source
Withdrawn
Robotic Rehabilitation for Stroke Survivors
“The PI moved to another institution.”Registry text, quoted unchanged. Source
Suspended
A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
“Potential unwrapping of the LAA post implant with clinically significant leaks.”Registry text, quoted unchanged. Source
Terminated
Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study
“The study was terminated prematurely due to lack of continued funding.”Registry text, quoted unchanged. Source
Terminated
“Enrollment was closed early in July 2025 because of slow recruitment (338 of 600 planned participants; 324 were required for the superiority comparison). The 12-month follow-up period for all randomized participants ended in July 2026.”Registry text, quoted unchanged. Source
Suspended
Comparative Efficacy of Saccadic and Biofeedback Training in Homonymous Hemianopia
“funding”Registry text, quoted unchanged. Source
Suspended
“Enrollment has been temporarily suspended out of an abundance of caution and in close consultation with trial leadership and regulatory bodies to review overall study data thoroughly following a serious adverse event.”Registry text, quoted unchanged. Source
Terminated
PET/MR in Post Stroke Cardiac Inflammation Study
“Study terminated prematurely due to recruitment challenges.”Registry text, quoted unchanged. Source
Withdrawn
Sweet spoT for cArdiac Rhythm monitorinG After sTrokE
“Withdrawn before enrollment because new clinical evidence made the study question no longer relevant.”Registry text, quoted unchanged. Source
Withdrawn
Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy
“The study was discontinued following the cessation of the company's activities, which resulted in the investigational medicinal product no longer being available.”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Submaximal Versus Maximal Isometric Tongue Training After Stroke
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Virtual Reality Training Dose for Arm Recovery After Stroke: Clinical and Blood Biomarker Responses
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 38
- Organoids 7
- Mendelian Randomization Analysis 167
- CRISPR-Cas Systems 4
- Gene Expression Profiling 74
- Sequence Analysis, RNA 12
- Exome Sequencing 8
- Proteomics 97
- Metabolomics 70
- Mass Spectrometry 12
- Flow Cytometry 12
- Immunohistochemistry 33
- Xenograft Model Antitumor Assays 1
- Positron-Emission Tomography 32
- Magnetic Resonance Imaging 848
- Machine Learning 350
- Deep Learning 123
- Cohort Studies 934
- Genome-Wide Association Study 139
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.